Lixisenatide as add-on therapy to basal insulin in type 2 diabetes

Lixisenatide as add-on therapy to basal insulin in type 2 diabetes

  • CN 103,717,232 A
  • Filed: 05/11/2012
  • Published: 04/09/2014
  • Est. Priority Date: 05/13/2011
  • Status: Active Application
First Claim
Patent Images

1. for a drug regimen for type 2 diabetes mellitus patient'"'"'s glycemic control, described combination comprises:

  • (a) desPro 36exendin-4 (1-39)-Lys 6-NH 2or/and its pharmaceutically acceptable salt, (b) basal insulin is or/and its pharmaceutically acceptable salt, and(c) optionally, metformin is or/and its pharmaceutically acceptable salt.

View all claims
    ×
    ×

    Thank you for your feedback

    ×
    ×